CADM2 and neoplasm: CADM2 suppression by miR-17 promotes tumor cell proliferation, migration, invasion, and dysregulation of the cell cycle [16], while HSBP2 downregulation disrupts programmed cell death, enhances clonogenic potential, and increases tumor cell survival [15].